MORO, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.042
AS - Asia 2.737
EU - Europa 2.485
SA - Sud America 34
AF - Africa 11
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 6
Totale 24.324
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.006
CN - Cina 1.291
SG - Singapore 808
VN - Vietnam 521
IT - Italia 510
FI - Finlandia 471
DE - Germania 400
UA - Ucraina 257
FR - Francia 249
SE - Svezia 214
GB - Regno Unito 166
IE - Irlanda 94
IN - India 44
CA - Canada 34
GR - Grecia 26
NL - Olanda 26
BR - Brasile 23
TR - Turchia 14
ES - Italia 12
JP - Giappone 10
PK - Pakistan 9
BG - Bulgaria 8
IR - Iran 8
KR - Corea 8
RU - Federazione Russa 8
PL - Polonia 7
TW - Taiwan 7
SI - Slovenia 6
AR - Argentina 5
AT - Austria 5
BE - Belgio 5
CH - Svizzera 5
CL - Cile 5
NZ - Nuova Zelanda 5
AU - Australia 4
HU - Ungheria 4
PH - Filippine 4
RO - Romania 4
GH - Ghana 3
HK - Hong Kong 3
ZA - Sudafrica 3
A1 - Anonimo 2
DZ - Algeria 2
EG - Egitto 2
EU - Europa 2
IL - Israele 2
NO - Norvegia 2
SA - Arabia Saudita 2
SS - ???statistics.table.value.countryCode.SS??? 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BZ - Belize 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
GT - Guatemala 1
ID - Indonesia 1
LT - Lituania 1
LU - Lussemburgo 1
MM - Myanmar 1
MY - Malesia 1
NG - Nigeria 1
NP - Nepal 1
PT - Portogallo 1
Totale 24.324
Salva come PNG Salva come JPEG
Città #
Fairfield 3.267
Woodbridge 1.987
Houston 1.437
Chandler 1.324
Ashburn 1.301
Jacksonville 1.191
Seattle 1.191
Cambridge 1.167
Wilmington 1.163
Ann Arbor 1.055
Singapore 648
Princeton 533
Dong Ket 517
San Diego 341
Beijing 316
Helsinki 211
Des Moines 204
Nanjing 170
Padova 168
Medford 161
Roxbury 128
Boardman 126
Santa Clara 120
Columbus 101
Dublin 91
Shenyang 65
Hebei 63
Guangzhou 55
Nanchang 52
Jiaxing 42
London 40
Norwalk 39
Ogden 39
Changsha 38
Falls Church 36
Jinan 36
Tianjin 36
Munich 34
Los Angeles 33
New York 32
Pune 23
Kharkiv 22
North York 20
Redwood City 19
Kilburn 18
Venice 18
Berlin 17
Indiana 17
Milan 15
Ningbo 14
Shanghai 14
Mestre 12
Dallas 11
Yenibosna 11
Zhengzhou 11
Lanzhou 10
Rome 10
Treviso 10
Washington 10
Borås 9
Camerino 9
Hangzhou 8
Hefei 8
Sofia 8
Verona 8
Hounslow 7
Kunming 7
São Paulo 7
Taizhou 7
Americana 6
Amsterdam 6
Chicago 6
Chiswick 6
Detroit 6
Frankfurt am Main 6
Haikou 6
Prescot 6
Taipei 6
Tappahannock 6
Brugherio 5
Council Bluffs 5
Kolkata 5
Lappeenranta 5
Las Vegas 5
Palermo 5
Philadelphia 5
Portland 5
San Jose 5
Santiago de Compostela 5
A Coruña 4
Cittadella 4
Clifton 4
Cordoba 4
Davao City 4
Florence 4
Lahore 4
Montréal 4
Mumbai 4
New Bedfont 4
Orange 4
Totale 20.072
Salva come PNG Salva come JPEG
Nome #
1,2,4-triazolo[4,3-a]quinoxalin-1-one moiety as an attractive scaffold to develop new potent and selective human A3 adenosine receptor antagonists: synthesis, pharmacological, and ligand-receptor modeling studies. 294
[1,2,4]Triazolo[1,5-c]pyrimidines as adenosine receptor antagonists: Modifications at the 8 position to reach selectivity towards A3 adenosine receptor subtype 291
1-Thioangelicin: crystal structure, computer-aided studies and photobiological activity 230
1-thiopsoralen, a new photobiologically active heteropsoralen. Photophysical, photochemical and computer aided studies 175
DockBench: An Integrated Informatic Platform Bridging the Gap between the Robust Validation of Docking Protocols and Virtual Screening Simulations 171
ALK Kinase Domain Mutations in Primary Anaplastic Large Cell Lymphoma: Consequences on NPM-ALK Activity and Sensitivity to Tyrosine Kinase Inhibitors. 167
Evaluating the effects of fluorine on biological properties and metabolic stability of some antitubulin 3-substituted 7-phenyl-pyrroloquinolinones 161
Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway 161
Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2 154
Synthesis, structure-activity relationships and biological evaluation of 7-phenyl-pyrroloquinolinone 3-amide derivatives as potent antimitotic agents 154
Deciphering the Complexity of Ligand-Protein Recognition Pathways Using Supervised Molecular Dynamics (SuMD) Simulations 148
Phenolic 1,3-diketones attenuate lipopolysaccharide-induced inflammatory response by an alternative magnesium-mediated mechanism 148
Support Vector Machine (SVM) as Alternative Tool to Assign Acute Aquatic Toxicity Warning Labels to Chemicals 146
The topoisomerase II poison clerocidin alkylates non-paired guanines of DNA: implications for the irreversible stimulation of DNA cleavage 144
A novel glucosyltransferase from Catharanthus roseus cell suspensions 142
Comparison of the Human A2AAdenosine Receptor Recognition by Adenosine and Inosine: New Insight from Supervised Molecular Dynamics Simulations 137
Prevalence, Tumorigenic Role, and Biochemical Implications of Rare BRAF Alterations. 136
Exploring Protein-Peptide Recognition Pathways Using a Supervised Molecular Dynamics Approach 135
Could the presence of sodium ion influence the accuracy and precision of the ligand-posing in the human A2A adenosine receptor orthosteric binding site using a molecular docking approach? Insights from Dockbench 132
Identification of ellagic acid as potent inhibitor of protein kinase CK2: a successful example of a virtual screening application. 132
Pyrazoloquinazoline tricyclic system as novel scaffold to design new kinase CK2 inhibitors 132
A versatile synthesis of the 1,4-dihydroxynaphthoquinone nucleus 127
Inhibition of protein kinase CK2 by condensed polyphenolic derivatives. An in vitro and in vivo study 126
Rational Design, Synthesis, and DNA Binding Properties of Novel Sequence-Selective Peptidyl Congeners of Ametantrone 124
Targeting tubulin polymerization by novel 7-aryl-pyrroloquinolinones: Synthesis, biological activity and SARs 124
USP15 is a deubiquitylating enzyme for receptor-activated SMADs. 122
Functional Significance of the Novel H-RAS Gene Mutation M72I in a Patient with Medullary Thyroid Cancer. 122
Correlation between One-Electron Reduction and Oxygen-Oxygen Bond Strength in d0 Transition Metal Peroxo Complexes. 122
Combining ligand-based and structure-based drug design in the virtual screening arena 121
6-aminoquinolones as new potential anti-HIV agents 120
Leukaemic cells from chronic lymphocytic leukaemia patients undergo apoptosis following microtubule depolymerization and Lyn inhibition by nocodazole. 119
AquaMMapS: an alternative tool to monitor the role of water molecules during protein-ligand association 119
Tetrabromocinnamic acid (TBCA) and related compounds represent a new class of specific protein kinase CK2 inhibitors 117
Understanding allosteric interactions in G protein-coupled receptors using Supervised Molecular Dynamics: A prototype study analysing the human A3 adenosine receptor positive allosteric modulator LUF6000 115
Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: a complete structure -activity profile. 114
DNA-Interactive Anticancer Aza-Anthrapyrazoles: Biophysical and Biochemical Studies Relevant to the Mechanism of Action 113
Coupling Supervised Molecular Dynamics (SuMD) with Entropy Estimations To Shine Light on the Stability of Multiple Binding Sites 113
Relationship between the structure and the DNA binding properties of diazoniapolycyclic duplex- and triplex-DNA binders: Efficiency, selectivity, and binding mode 111
Could Adenosine Recognize its Receptors with a Stoichiometry Other than 1 : 1? 111
Protein Kinase CK2 Inhibitors: Emerging Anticancer Therapeutic Agents? 110
Exploring Potency and Selectivity Receptor Antagonist Profiles Using a Multilabel Classification Approach: The Human Adenosine Receptors as a Key Study 110
Novel 3-Substituted 7-Phenylpyrrolo[3,2-f]quinolin-9(6H)-ones as Single Entities with Multitarget Antiproliferative Activity 110
New Trends in Inspecting GPCR-ligand Recognition Process: the Contribution of the Molecular Modeling Section (MMS) at the University of Padova 110
New benzoquinolizin-5-one derivatives as furocoumarin analogs: DNA interactions and molecular modeling studies 110
Flavonoids diosmetin and hesperetin are potent inhibitors of cytochrome P450 2C9-mediated drug metabolism in vitro. 109
A Novel Generalized 3D-QSAR Model of Camptothecin Analogs 108
The mitochondrial calcium uniporter is a multimer that can include a dominant-negative pore-forming subunit. 108
The Significance of 2-Furyl Ring Substitution with a 2-(para-substituted) Aryl Group in a New Series of Pyrazolo-triazolo-pyrimidines as Potent and Highly Selective hA(3) Adenosine Receptors Antagonists: New Insights into Structure-Affinity Relationship and Receptor-Antagonist Recognition 107
Novel camptothecin derivatives as topoisomerase I inhibitors 107
Targeting Protein Kinase CK1δ with Riluzole: Could It Be One of the Possible Missing Bricks to Interpret Its Effect in the Treatment of ALS from a Molecular Point of View? 107
Comparative studies on the DNA-binding properties of linear and angular dibenzoquinolizinium ions 106
Ab initio calculations on water-peroxovanadium clusters, VO(O-2)(H2O)(n)(+) (n=1-5). Implications for the structure in aqueous solution 106
DockBench as docking selector tool: the lesson learned from D3R Grand Challenge 2015 106
A theoretical and experimental investigation of the electrophilic oxidation of thioethers and sulfoxides by peroxides 105
Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: Effect of the N-5 bond type on the affinity and selectivity at the four adenosine receptor subtypes 104
SAR and QSAR study on 2-aminothiazole derivatives, modulators of transcriptional repression in Huntington's disease 104
Reactivity of Clerocidin towards adenine: implications for base modulated DNA damage 104
MMsINC: a large-scale chemoinformatics database 104
Indolo[2,3-b]-quinolizinium bromide: an efficient intercalator with DNA-photodamaging properties 104
G protein-coupled receptors as challenging druggable targets: insights from in silico studies 102
DNA-binding preferences of bisantrene analogues: Relevance to the sequence specificity of drug-mediated topoisomerase II poisoning 102
Designing a ligand for pharmaceutical purposes 101
Semisynthesis, Biological Activity, and Molecular Modeling Studies of C-Ring-Modified Camptothecins 101
Structural investigation of the 7-chloro-3-hydroxy-1H-quinazoline-2,4-dione scaffold to obtain AMPA and kainate receptor selective antagonists. Synthesis, pharmacological, and molecular modeling studies 99
Advances in GPCR modeling evaluated by the GPCR Dock 2013 assessment: meeting new challenges. 99
Titanium(IV)-(R,R,R)-tris(2-phenylethoxy)amine-alkylperoxo complex mediated oxidations: The biphilic nature of the oxygen transfer to organic sulfur compounds 99
BACE1 inhibitory activities of enantiomerically pure, variously substituted N-(3-(4-benzhydrylpiperazin-1-yl)-2-hydroxypropyl) arylsulfonamides 98
GTP-dependent packing of a three-helix bundle is required for atlastin-mediated fusion 98
Elucidation of the ribonuclease a aggregation process mediated by 3D domain swapping: A computational approach reveals possible new multimeric structures. 98
Tandem 3D-QSARs approach as a valuable tool to predict binding affinity data: Design of new Gly/NMDA receptor antagonists as a key study 98
PEG-Ara-C conjugates for controlled release 98
7-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: structural investigations at the 5-position to target human A? and A(2A) adenosine receptors. Molecular modeling and pharmacological studies. 97
Toward the rational design of protein kinase casein kinase-2 inhibitors 97
Perturbation of fluid dynamics properties of water molecules during G protein-coupled receptor-ligand recognition: the human A2A adenosine receptor as a key study. 97
The chemistry of peroxovanadium species in aqueous solutions, Structure and reactivity of a neutral diperoxovanadium complex as provided by V-51-NMR data, ab initio calculations and kinetic results 96
The versatile chemistry of peroxo complexes of vanadium, molybdenum and tungsten as oxidants of organic compounds 96
Tuning the activity of Zn(II) complexes in DNA cleavage: Clues for design of new efficient metallo-hydrolases 96
Protein kinase CK2 inhibitors: a patent review 96
Bridging molecular docking to molecular dynamics in exploring ligand-protein recognition process: An overview 96
Can We Still Trust Docking Results? An Extension of the Applicability of DockBench on PDBbind Database 96
Use of electrospray ionization mass spectrometry to characterize chiral reactive intermediates in a titanium alkoxide mediated sulfoxidation reaction 95
5,7-Disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazines as pharmacological tools to explore the antagonist selectivity profiles toward adenosine receptors 94
Pharmaceutical Perspectives of Nonlinear QSAR Strategies 94
Demystifying the three dimensional structure of G protein- coupled receptors (GPCRs) with the aid of molecular modeling 93
Advances in Computational Techniques to Study GPCR-Ligand Recognition 93
Conjugates between minor groove binders and Zn(II)-tach complexes: Synthesis, characterization, and interaction with plasmid DNA 93
A Triazolotriazine-Based Dual GSK-3β/CK-1δ Ligand as a Potential Neuroprotective Agent Presenting Two Different Mechanisms of Enzymatic Inhibition 93
A High-Throughput Screening Identifies MICU1 Targeting Compounds 93
PCA-Based Representations of Graphs for Prediction in QSAR Studies 91
Mapping drug interactions at the covalent topoisomerase II-DNA complex by bisantrene/amsacrine congeners 91
Amide bond direction modulates G-quadruplex recognition and telomerase inhibition by 2,6 and 2,7 bis-substituted anthracenedione derivatives. 91
Inhibition of cytochrome P450 2C8-mediated drug metabolism by the flavonoid diosmetin. 91
2-Heteroarylbenzamide derivatives as MEK kinase inhibitors with antitumor activity 90
Urolithin as a converging scaffold linking ellagic acid and coumarin analogues: design of potent protein kinase CK2 inhibitors. 90
Comparison of Multilabel and Single-Label Classification Applied to the Prediction of the Isoform Specificity of Cytochrome P450 Substrates 90
Revisiting the Allosteric Regulation of Sodium Cation on the Binding of Adenosine at the Human A2A Adenosine Receptor: Insights from Supervised Molecular Dynamics (SuMD) Simulations 90
3-Hydroxy-1H-quinazoline-2,4-dione derivatives as new antagonists at ionotropic glutamate receptors: Molecular modeling and pharmacological studies 89
In silico investigation of PHD-3 specific HIF1-α proline 567 hydroxylation: a new player in the VHL/HIF-1α interaction pathway? 89
Synthesis of brominated compounds. A convenient molybdenum-catalyzed procedure inspired by the mode of action of haloperoxidases. 88
2-Phenylpyrazolo[4,3-d]pyrimidin-7-one as a New Scaffold To Obtain Potent and Selective Human A(3) Adenosine Receptor Antagonists: New Insights into the Receptor-Antagonist Recognition 88
Totale 11.655
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.949
article - articoli 89.895
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 557
selected - selezionate 0
volume - volumi 1.102
Totale 186.503
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.023 0 0 0 378 516 423 443 580 597 562 286 238
2020/20213.928 176 254 143 354 163 306 55 322 544 480 452 679
2021/20224.342 102 515 625 336 145 181 240 569 213 95 496 825
2022/20233.160 648 210 40 343 523 490 11 254 399 57 141 44
2023/20241.961 115 297 301 136 193 141 170 83 83 53 196 193
2024/20251.321 33 681 342 265 0 0 0 0 0 0 0 0
Totale 24.551